Rising Pharmaceuticals has launched the generic version of the 75mg/*5mL strength of Clindamycin Palmitate Hydrochloride for Oral Solution,USP(Pediatric).
Clindamycin Palmitate Hydrochloride used to treat infections caused by bacteria,is a FDA approved generic version of Pfizer's Cleocin Pediatric.
According to IMS Health data,Clindamycin Palmitate Hydrochloride had sales nearly$59m for the twelve months ended 30 June 2012.
Rising Pharmaceuticals is a finished dosage form generics subsidiary to ACETO Corporation,which markets,sells and distributes products for human health,pharmaceutical ingredients and performance chemicals.